Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts Is Latest PBM To Ink Settlement With State Attorneys General

Executive Summary

Express Scripts is the third pharmacy benefits management company to reach a settlement with states over alleged deceptive prescribing practices

You may also be interested in...



Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca

Medco Health Solutions and AstraZeneca have received subpoenas from the DoJ for information involving arrangements pertaining to four AstraZeneca drugs.

Pharma Industry Watchdog Brill Nominated For FTC Commissioner

Julie Brill, who has had a long-standing interest in pharmaceutical industry pricing and marketing practices, has been nominated to be one of the five commissioners of the Federal Trade Commission

Pharma Industry Watchdog Brill Nominated For FTC Commissioner

Julie Brill, who has had a long-standing interest in pharmaceutical industry pricing and marketing practices, has been nominated to be one of the five commissioners of the Federal Trade Commission

Related Content

UsernamePublicRestriction

Register

PS049696

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel